XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SUBSEQUENT EVENTS (Details) - Subsequent Event - Genentech, Roche Group - License
$ in Millions
Aug. 02, 2024
USD ($)
Subsequent Event [Line Items]  
Variable consideration amount $ 10.0
Deferred revenues 40.0
Remaining performance obligation amount $ 1,900.0